Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000291618 | SCV000335642 | likely benign | not specified | 2015-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620979 | SCV000736515 | likely benign | Cardiovascular phenotype | 2016-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000866023 | SCV001007062 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000291618 | SCV001365476 | benign | not specified | 2019-12-23 | criteria provided, single submitter | clinical testing | The p.Glu14763Gln variant in TTN is classified as benign because it has been identified in 0.5% (162/29828) of South Asian chromosomes and 5 homozygotes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. |
Gene |
RCV001712001 | SCV001940463 | benign | not provided | 2018-12-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840473 | SCV002100562 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840474 | SCV002100563 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840475 | SCV002100564 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840472 | SCV002100566 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977756 | SCV004794980 | likely benign | TTN-related condition | 2022-03-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |